Commentaries

September 22 2009

Follow-on biologic drug competition – No need for new marketing exclusivities

Michael S Wroblewski and Elizabeth A Jex

J Commer Biotechnol advance online publication, September 22, 2009; doi:10.1057/jcb.2009.27

Abstract | Full Text | PDF

Original Articles

November 10 2009

The current M&A environment and its strategic implications for emerging biotherapeutics companies

Mohan Sowlay and Scott Lloyd

J Commer Biotechnol advance online publication, November 10, 2009; doi:10.1057/jcb.2009.35

Abstract | Full Text | PDF

Biotechnology in the capital region of Europe

Jan Wauters

J Commer Biotechnol advance online publication, November 10, 2009; doi:10.1057/jcb.2009.34

Abstract | Full Text | PDF

November 3 2009

Practical approaches to early stage life sciences technology valuations

Stephen Mayhew

J Commer Biotechnol advance online publication, November 3, 2009; doi:10.1057/jcb.2009.31

Abstract | Full Text | PDF

October 27 2009

From carbon to carbohydrates: Corporate strategies for biopolymer technology development

Avrath Chadha

J Commer Biotechnol advance online publication, October 27, 2009; doi:10.1057/jcb.2009.30

Abstract | Full Text | PDF

Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime

Trichi Saukshmya and Archana Chugh

J Commer Biotechnol advance online publication, October 27, 2009; doi:10.1057/jcb.2009.28

Abstract | Full Text | PDF

August 11 2009

Ethiopia: Biotechnology for development

Desta Berhe Sbhatu

J Commer Biotechnol advance online publication, August 11, 2009; doi:10.1057/jcb.2009.21

Abstract | Full Text | PDF

May 26 2009

Biotechnology marketing: Insider and outsider views

Päivi Eriksson and Heidi Rajamäki

J Commer Biotechnol advance online publication, May 26, 2009; doi:10.1057/jcb.2009.16

Abstract | Full Text | PDF

Challenges and opportunities in the licensing of renewable technologies

Meredith Lloyd-Evans, Mike Gilbert and Ilian P Iliev

J Commer Biotechnol advance online publication, May 26, 2009; doi:10.1057/jcb.2009.10

Abstract | Full Text | PDF

April 21 2009

Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb

Nigel Borshell and Adrian Dawkes

J Commer Biotechnol advance online publication, April 21, 2009; doi:10.1057/jcb.2009.13

Abstract | Full Text | PDF

April 7 2009

Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms

Mark J Ahn, Michael Meeks, Sally Davenport and Rebecca Bednarek

J Commer Biotechnol advance online publication, April 7, 2009; doi:10.1057/jcb.2009.8

Abstract | Full Text | PDF

March 17 2009

Intellectual property landscape and patenting opportunity in biofuels

Ramasamy Mannan

J Commer Biotechnol advance online publication, March 17, 2009; doi:10.1057/jcb.2009.1

Abstract | Full Text | PDF